IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Katica Schwarz

USPTO Granted Patents = 18

Average Co-Inventor Count = 6.5

ph-index = 7

Forward Citations = 149(Granted Patents)


Company Filing History:

goldMedal17 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 4 
 
Schering Aktiengellschaft
 patents

Years Active: 1977-2006

Loading Chart...
18 patents (USPTO):Explore Patents
1. 7115758 - Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents (2006-10-03),
2. 7071344 - Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments (2006-07-04),
3. 6642218 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2003-11-04),
4. 6613920 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents (2003-09-02),
5. 6603031 - Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents (2003-08-05),
6. 6600058 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2003-07-29),
7. 6531459 - Vitamin D derivatives with phosphorus atoms in the side chains (2003-03-11),
8. 6376480 - Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents (2002-04-23),
9. 6372731 - Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments (2002-04-16),
10. 5700791 - Vitamin D derivatives modified in the 20-position and pharmaceutical (1997-12-23),
11. 5663157 - 22-en-25-oxa derivatives in the vitamin D series, process for their (1997-09-02),
12. 5585368 - 20-position modified pharmaceutically active vitamin D series compounds (1996-12-17),
13. 5583125 - 25-Carboxylic acid derivatives in the vitamin D series, process for (1996-12-10),
14. 5532228 - Side-chain homologous vitamin D derivatives, process for their (1996-07-02),
15. 5446035 - 20-methyl-substituted vitamin D derivatives (1995-08-29),

Title: Katica Schwarz: Pioneering Innovator in Vitamin D Derivatives

Introduction

Katica Schwarz, a prominent inventor based in Berlin, Germany, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 18 patents, her work primarily focuses on vitamin D derivatives and their applications in the production of medicaments.

Latest Patents

Among her latest innovations are two pivotal patents pertaining to vitamin D derivatives. The first patent details the development of vitamin D derivatives featuring cyclic substructures in the side chains, along with processes and intermediate products for their production. This invention has particular relevance in the pharmaceutical industry, highlighting the use of these derivatives in the formulation of pharmaceutical agents. The second patent introduces vitamin D derivatives with cyclopropyl rings in their lateral chains, alongside a method for their production and the utilization for producing medicaments. Both inventions represent significant advancements in the development of new therapeutic agents.

Career Highlights

Throughout her career, Katica Schwarz has been associated with notable companies, including Schering Aktiengesellschaft. Her work at these institutions has allowed her to refine her research and innovation skills, contributing to the advancement of pharmaceutical technology.

Collaborations

Katica has collaborated with esteemed colleagues such as Andreas Steinmeyer and Gerald Kirsch. These partnerships have fostered a collaborative environment that has led to the successful completion of innovative projects and the advancement of their collective work in the field.

Conclusion

Katica Schwarz's dedication to research and her innovative spirit have established her as a key figure in the development of vitamin D derivatives. Her 18 patents underscore her role as a leading inventor in the pharmaceutical industry, and her contributions continue to enhance the landscape of medical treatments and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…